Similar Items: Soluble tumor necrosis factor receptors in diabetes: risk sensing and receptor-resolved targeting
- Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy
- Metabolic and Glycemic Effects of Orforglipron, a GLP‐1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta‐Analysis of Randomised Clinical Trials
- The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
- Therapeutic implications of peroxisome proliferator-activated receptors in non-small cell lung cancer
- Derivation and external validation of a prognostic nomogram for human epidermal growth factor receptor 2 negative early young breast cancer in women
- Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor